Back

Oncologic radiotherapy-induced implantable cardioverter-defibrillator malfunctions: a real-time, in-vitro evaluation

1 September 2019 (17:41 - 17:50)
Organised by:
Congress Presentation Part of: Optimizing device therapy for arrhythmia Implantable Cardioverter-Defibrillator (ICD) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Enrico Di Girolamo

Lanciano Renzetti Hospital, Lanciano (Italy)

7 More presentations in this session

Presentation thumbnail
Experience with the wearable cardioverter-defibrillator by disease etiology: results from the wearit-II registry
Associate Professor V. Kutyifa (Rochester, US)
Abstract Slides Video
Presentation thumbnail
The use of wearable cardioverter defibrillator in France
Professor E. Marijon (Paris, FR)
Abstract
Presentation thumbnail
When do cardiac rhythm management device complications occur?
Doctor C. Brough (Cheshire, GB)
Abstract Slides Video
Presentation thumbnail
Role of implantation access on complication rates in pacemaker implantation
Doctor K. Bestehorn (Dresden, DE)
Abstract Slides Video
Presentation thumbnail
Influence of transvenous lead extraction procedure on function of tricuspid apparatus
Professor A. Polewczyk (Kielce, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Optimizing device therapy for arrhythmia

The Event

Event poster

ESC Congress 2019

1 September 2019 17:41 CET
You may be interested in
thumbnail
Congress Session
Debate on primary prevention in ICD therapy
thumbnail
Congress Session
Implantable cardioverter defibrillator therapy
thumbnail
Congress Session
Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources